AT
Abhishek Trivedi
About Abhishek Trivedi
Data last updated:
Abhishek Trivedi is a Director at Regis Medichem Private Limited (since 2019) and Director at Vedgiri Ayurveda Private Limited (since 2022). The companies operate in Home Appliances and Chemicals. The largest current company by reported revenue is Regis Medichem Private Limited at ₹5.6 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Regis Medichem Private Limited U52311UP2019PTC115353 | Director | 01 Apr 2019 | 2019 | ₹5.6 Lakh (FY 2024) | Active |
| Vedgiri Ayurveda Private Limited U24290UP2022PTC169824 | Director | 29 Aug 2022 | 2022 | Active |
Board colleagues of Abhishek Trivedi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shobhit Jaiswal | 03100095 | Regis Medichem Private Limited | Director |
| Nishant Singh Jadaun | 08111007 | Vedgiri Ayurveda Private Limited | Director |
| Shanti Swaroop Shukla | 09720224 | Vedgiri Ayurveda Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Abhishek Trivedi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abhishek Trivedi
Abhishek Trivedi currently holds 2 directorships: Regis Medichem Private Limited (Director, since 01 Apr 2019, revenue ₹5.6 Lakh (FY 2024)); Vedgiri Ayurveda Private Limited (Director, since 29 Aug 2022).
Abhishek Trivedi was first appointed on 01 Apr 2019 as Director at Regis Medichem Private Limited. The most recent appointment on record is 29 Aug 2022 at Vedgiri Ayurveda Private Limited.
The current boards of Abhishek Trivedi's companies include Shobhit Jaiswal (Regis Medichem Private Limited), Nishant Singh Jadaun (Vedgiri Ayurveda Private Limited), Shanti Swaroop Shukla (Vedgiri Ayurveda Private Limited).